Syros Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SYRS and buy or sell other stocks, ETFs, and their options commission-free!About SYRS
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609.
CEONancy A. Simonian
CEONancy A. Simonian
Employees124
Employees124
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2011
Founded2011
Employees124
Employees124
SYRS Key Statistics
Market cap6.30K
Market cap6.30K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume5.31M
Average volume5.31M
High today$0.0005
High today$0.0005
Low today$0.0001
Low today$0.0001
Open price$0.0005
Open price$0.0005
Volume4.34K
Volume4.34K
52 Week high$5.22
52 Week high$5.22
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
As of today, Syros Pharmaceuticals(SYRS) shares are valued at $0.00. The company's market cap stands at 6.3K.
During the trading session on 2026-06-10, Syros Pharmaceuticals(SYRS) shares reached a daily high of $0.00 and a low of $0.00. At a current price of $0.00, the stock is 0.0% higher than the low and still -80.0% under the high.
Trading activity shows a volume of 4.34K, compared to an average daily volume of 5.31M.
Over the past 52 weeks, Syros Pharmaceuticals(SYRS) stock has traded between a high of $5.22 and a low of $0.00.
Over the past 52 weeks, Syros Pharmaceuticals(SYRS) stock has traded between a high of $5.22 and a low of $0.00.
People also own
Based on the portfolios of people who own SYRS. This list is generated using Robinhood data, and it’s not a recommendation.